We need your support
Latest News >
Archive
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec bibendum, velit non ornare posuere, tellus arcu sollicitudin est, dapibus venenatis velit magna id risus. Curabitur et ante libero. Quisque eu neque vitae eros adipiscing ultricies non id risus. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Suspendisse potenti. Suspendisse imperdiet elementum augue, eget dictum lorem ornare quis. Nunc convallis felis eget felis rhoncus sed tempus lectus placerat. Cras vehicula blandit nunc vel porta. Aliquam non dui enim, tempus tempor mi. In placerat pellentesque tempor. Quisque placerat tortor ac risus rhoncus adipiscing. Donec in odio ut ligula rutrum interdum eu ut dui. Curabitur pharetra semper ante eu auctor. Vivamus non rhoncus magna. Fusce in metus tortor, a faucibus sem. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Proin nec mollis massa. Aenean feugiat feugiat iaculis. Pellentesque in nibh nec eros dapibus sagittis. Suspendisse pellentesque euismod elementum. Nam et purus vitae neque tincidunt pharetra eget nec erat. Sed a venenatis sem. Nam elementum faucibus adipiscing. Etiam et leo vitae sapien blandit sodales eu vel nisi. Morbi nibh nibh, pretium et vehicula non, pellentesque quis odio. Aliquam vitae nunc libero, in varius ipsum. Donec blandit tincidunt leo, eget mattis nisl elementum ut. Fusce interdum metus vitae mi porttitor vitae condimentum ante lacinia. Aenean a leo massa, in vulputate odio. Duis pharetra consequat nunc, eu consectetur tortor suscipit a. Integer ornare aliquet diam a convallis. Duis vel lorem viverra tortor accumsan suscipit. Vestibulum pellentesque, purus quis blandit malesuada, risus metus vestibulum neque, nec facilisis diam turpis non nulla. Nam ligula magna, fermentum sed vulputate sed, feugiat ut eros. Integer semper aliquam orci a laoreet. Sed dapibus leo et nibh euismod hendrerit. Fusce ac auctor urna. Donec dolor arcu, commodo eget congue vel, viverra eget sapien. Nullam cursus venenatis enim sit amet tempus. Nullam vel nunc dolor. Nunc porta eros sit amet est varius lacinia. Vivamus id lacus purus. Nulla facilisi. Aliquam erat volutpat. Praesent in justo tellus. Mauris feugiat massa et eros aliquam at convallis turpis ultricies. Praesent vitae feugiat magna. Suspendisse magna tortor, tristique quis lacinia sit amet, facilisis eget magna. Nunc et mi nec ipsum tempor porttitor. In ornare metus quis orci fermentum elementum ac vitae eros. Cras placerat, ante vitae viverra laoreet, mi dui commodo nisl, quis ullamcorper metus felis a lectus. Donec metus est, rhoncus in vulputate ac, interdum porttitor neque. Morbi consequat velit aliquam elit scelerisque sit amet vulputate erat venenatis. Aliquam bibendum porttitor augue id euismod. Vivamus vel dapibus massa. Vestibulum ornare euismod tempus. Donec et mauris a turpis varius ultricies. Praesent molestie tempor enim sed molestie. Praesent ut tempus lacus. Proin sed dolor id lectus aliquam elementum a vitae lacus. Vestibulum erat libero, tincidunt a lobortis vitae, ultricies vitae metus. Mauris sapien odio, mollis vitae molestie ut, rhoncus eget orci. In malesuada nisl sed nulla imperdiet consectetur.

Archive pour March 2025

Rosanne’s Scleroderma Journey
24 March 2025 Par Chelsea Fitzpatrick

Every journey with scleroderma is unique, but one thing unites us all—hope. Faces of Hope shares the real stories of resilience, strength, and courage from members of the Scleroderma Association of BC. These personal testimonies shine a light on the challenges and triumphs of living with scleroderma, inspiring connection and understanding.

Read Rosanne’s story and discover more voices of hope here

 

Advocate for Sotatercept!
17 January 2025 Par Chelsea Fitzpatrick

People living with scleroderma face unique challenges. For some, those challenges include developing pulmonary arterial hypertension (PAH)—a progressive and life-threatening condition. Timely diagnosis and access to new treatments can make all the difference, but too often, patients face delays that can cost them their health and quality of life.

In August 2024, Health Canada approved sotatercept (Winrevair), a breakthrough treatment that offers hope to PAH patients, including those in our scleroderma community. Canada’s Drug Agency has now recommended that sotatercept be publicly funded. For this treatment to become accessible to patients, the pan-Canadian Pharmaceutical Alliance (pCPA) must negotiate pricing and funding with the manufacturer on behalf of the provincial drug programs.

That’s why we’re proud to support PHA Canada’s Time Matters PAH campaign—an advocacy initiative pushing for timely access to sotatercept, a breakthrough treatment that offers hope to PAH patients, including those in our scleroderma community.

 

Here’s how you can help—and it’s simple:
✅ Take 2 minutes to send a pre-written letter to your provincial health minister.
✅ Share this with your family and friends to amplify your impact.

 

 

Every voice matters.

By speaking up, you are helping pulmonary arterial hypertension (PAH) patients access this new treatment.

Take action now ➡️ www.phacanada.ca/advocate

 

Together, we can ensure timely access to life-changing treatment for PAH patients in Canada.

 

Click here for a downloadable PAH-fact-sheet.pdf

 

 

With gratitude,

The Scleroderma Association of B.C.

 

 

Scleroderma.Ai
30 October 2024 Par Chelsea Fitzpatrick

Patients with Scleroderma can often be recognized by changes in their faces and hands.

Scleroderma.AI is a research project trying to determine if we can use artificial intelligence (AI) and facial recognition technologies to early diagnose Scleroderma. Our team consists of well known scleroderma researchers – Dr. Daniel E. Furst and Dr. Yossra Suliman as well as technology entrepreneurs Thomas Winkler, Jerry Wi, and Amyn Rajan (SABC Board Member). 
 
We hypothesize that facial and hand features of Scleroderma patients are distinctive and can be detected by a trained AI system after processing a picture of a Scleroderma patient’s face and hands. This system could be used by family practitioners and internists, aiding them to increase suspicion of Scleroderma and refer patients in a timely manner. We are looking for Scleroderma Warriors who can assist us in the endeavour. You can find out more at SCLERODERMA.AI 
 
Best wishes,
Amyn Rajan,
SABC Board Member

 

Clinical Trial
21 August 2024 Par Chelsea Fitzpatrick

If you are living with scleroderma, joining the VITALISScE™ study might be a suitable option for you.

The VITALISScE™ study is looking at an investigational medicine called BI 685509 as a potential treatment for people who have systemic sclerosis (scleroderma).

You may be able to participate if you:

  • Are 18 years of age or older
  • Have been diagnosed with systemic sclerosis in the past 7 years
  • Are dealing with worsening of skin thickening or if your condition has spread to new areas
    of your body

Other requirements will need to be met to take part in the study.

Participants in the VITALISScE™ study (also known as clinical trial 1366-0031) will be joining a global effort to find better choices for treatment in the future for people living with scleroderma.
Taking part in the VITALISScE™ study is free and you may receive reimbursement for study-related expenses (for example, travel and meals).

Contact VITALISScE™ to find out more:

Study Coordinator: Mindy Mok
Email:mmok4@providencehealth.bc.ca
Phone: 604-806-8117 EXT 68117

 

Official Study Poster & Brochure:

Brochure – VITALISScE™ Study – sGCa in SSc

Poster – VITALISScE™ Study – sGCa in SSc

40th AGM & Conference
Par Chelsea Fitzpatrick

Join us Saturday October 26th 2024 at the Alan Emmott Centre in Burnaby for our 40th AGM & Conference.

REGISTER HERE

 

Join us for our 40th Annual AGM Meeting, followed by presentations from: 

Dr Joseph Pellizzari 
UPHEAVAL, CONNECTION & MEANING-MAKING:
Reflections on Coping with Scleroderma

Dr. John Swiston & Lisa Kolkman  
Pulmonary Hypertension in Scleroderma

Dr. Sarvee Moosavi
Scleroderma & The Gut

& the Lihong Yang Memorial Scholarship Award

Throughout the day, enjoy networking opportunities during breaks, lunch.

Visit the SABC Research Team & PHA at their booths.

 

*SOCIAL HOUR*

End the day with a social hour! Mingle & connect with scleroderma warriors from across the province.

 

 

 


Detailed Timeline 2024

 

40th AGM and Conference

Saturday, October 26th 2024

 

10:00   Registration   

Conference kit pickup and registration

Coffee/tea/juices/water available.

10:30   SABC AGM      

Introductions, adoption of agenda, approval of 2023 AGM minutes, receipt of Directors’ Report, elections & new business, if any.

MORNING SESSION:

11:00   Dr. Joseph Pellizzari

UPHEAVAL, CONNECTION & MEANING-MAKING:

Reflections on Coping with Scleroderma

12:15   Lunch/Chat break

AFTERNOON SESSION:

 

1:20     Lihong Yang Memorial Scholarship Award

1:30     Dr. John Swiston & Lisa Kolkman

Pulmonary Hypertension in Scleroderma

2:30    Break

2:50    Dr. Sarvee Moosavi

Scleroderma & The Gut

4:00   Closing Remarks

4:15   Social Hour

 

5:30      Adjournment

 

 

Hotel Reservations

SABC has arranged a group rate of $189/night at the Holiday Inn Express ® | Metrotown, 4405 Central Boulevard, Burnaby, BC, V5H 4M3

Tel: 604-438-1881

www.hiexpress.com/yvr-burnaby

When making a reservation online, include the check in and out dates, then choose ‘group rate’ from the drop down menu and enter group code ‘SCE’, then search.

 

 

Board Members Needed
Par Chelsea Fitzpatrick

Join our Board

As SABC celebrates its 40th anniversary, our commitment to supporting the community remains stronger than ever. To ensure we continue this important work for years to come, we are seeking dedicated community representatives and new board members to join us in October 2025. This is especially important as a few of our valued members will be stepping down in October 2026. We invite passionate individuals who share our vision to step forward and help us shape a brighter future together.

Our Mission
Our mission is threefold and drives everything we do each year:

  • Patient Support: promoting patient outreach and education.
  • Raise Awareness: Developing information tools and educating the general public and the medical community about scleroderma. 
  • Research Engagement: support cutting-edge research in British Columbia and Canada.

 

What We Do

Our activities and responsibilities include:

  • Monthly Board Meetings: we host monthly board meetings, usually on Sundays from 10:00 AM to 12:00 PM to discuss updates and brainstorm creative ways to expand our outreach.
  • Monthly Meetings: Held on Zoom, usually on Sundays from 10:00 am to 12:00 pm.
  • June Events/ Scleroderma Awareness Month: During June, we host events to fundraise for scleroderma research, including social events and a walk/run/bike around the seawall of Stanley Park.
  • Bulletin Magazine: We draft, edit and publish an annual Bulletin Magazine to provide updates on the latest events and communications from patients, board members, and medical professionals.
  • Sclerodata Newsletter: Sent annually to patients via email and mail.
  • Annual General Meeting & Conference: Held in October, our AGM educates patients about the latest scleroderma research with presentations on basic science, clinical research, lifestyle, and psychosocial research.
  • Patient Support Line: We answer questions from patients, caregivers, and individuals interested in volunteering or donating via email or phone
  • Advocacy: Spreading awareness and educating medical professionals and the general public about chronic illness and the challenges of scleroderma

 

Where We Need Help

  • Social Media: Assistance in managing and growing our social media presence.
  • Fundraising Ideas: Innovative thinkers to develop novel fundraising ideas.
  • Website and Canada Helps: Individuals with computer science backgrounds to help update our website and Canada Helps platform.
  • Research Fund Allocation: Help in reviewing and deciding where research funds should be allocated.
  • Content Development: Writers and editors to develop content for the magazine and Sclerodata newsletter.
  • Clinical and Basic Science Research: Support for evidence-based clinical and basic science research to expedite clinical trials and therapeutics for scleroderma.
  • Advocacy: Spreading awareness and educating medical professionals and the general public about chronic illness to expedite research & therapeutics.

 

Who You Are

We are seeking individuals who:

  • Are passionate about making a difference in the lives of those affected by scleroderma.
  • Possess skills or experience in areas such as social media, fundraising, content creation, or advocacy.
  • Are willing to commit a few hours a month to volunteer efforts.
  • Enjoy working collaboratively within a team.
  • You have a personal connection to scleroderma, or simply a strong desire to support our mission.

You do not need to have scleroderma, but you must be committed to helping us continue our mission. Whether you are a friend, family member, or someone with a few hours a month to spare, your contribution can make a significant difference.

 

Our Teams

You won’t be working alone! Our teams include:

  • Financial
  • Communication
  • Support
  • Research
  • Events
  • Fundraising
  • Advocacy

We are a dedicated and fun group of people, each bringing unique skills and passions to make a difference. Volunteering for this community is incredibly rewarding, which is why many of our members have been on the board for years and why we have thrived for the past 40 years.

 

Apply Now

Join us and be a part of something meaningful!

Phone:          1-604-371-1005

E-Mail:           info@sclerodermabc.ca 

 

⬆️